Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM

Clinical trial NCT05271240 · RECRUITING

Trial details

NCT number: NCT05271240
Sponsor: Northwell Health
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma Glioblastoma Multiforme Glioma, Malignant GBM Brain Cancer Glioblastoma, IDH-wildtype Glioblastoma Multiforme, Adult

Start date: 2022-04-27
Primary completion: 2027-04-01
Enrollment: 432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.